Raras
Buscar doenças, sintomas, genes...
Poliomielite
ORPHA:2912CID-10 · A80.4CID-11 · 1C81DOENÇA RARA

Doença infecciosa aguda que afeta o sistema nervoso. É causada pelo poliovírus. O vírus se espalha por contato direto e pode ser prevenido pela profilaxia com a vacina contra a poliomielite.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença infecciosa aguda que afeta o sistema nervoso. É causada pelo poliovírus. O vírus se espalha por contato direto e pode ser prevenido pela profilaxia com a vacina contra a poliomielite.

Pesquisas ativas
16 ensaios
317 total registrados no ClinicalTrials.gov
Publicações científicas
17.988 artigos
Último publicado: 2026 Apr 10

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: A80.4
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
10 sintomas
🫁
Pulmão
4 sintomas
🫃
Digestivo
3 sintomas
🦴
Ossos e articulações
2 sintomas
🧠
Neurológico
2 sintomas
🛡️
Imunológico
2 sintomas

+ 39 sintomas em outras categorias

Características mais comuns

90%prev.
Dor
Muito frequente (99-80%)
90%prev.
Fraqueza muscular
Muito frequente (99-80%)
55%prev.
Hipoplasia da musculatura
Frequente (79-30%)
55%prev.
Mielite
Frequente (79-30%)
55%prev.
Morfologia anormal do músculo esquelético
Frequente (79-30%)
55%prev.
Flacidez muscular
Frequente (79-30%)
63sintomas
Muito frequente (2)
Frequente (24)
Ocasional (19)
Muito raro (8)
Sem dados (10)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 63 características clínicas mais associadas, ordenadas por frequência.

DorPain
Muito frequente (99-80%)90%
Fraqueza muscularMuscle weakness
Muito frequente (99-80%)90%
Hipoplasia da musculaturaHypoplasia of the musculature
Frequente (79-30%)55%
MieliteMyelitis
Frequente (79-30%)55%
Morfologia anormal do músculo esqueléticoAbnormal skeletal muscle morphology
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico17.988PubMed
Últimos 10 anos200publicações
Pico2025153 papers
Linha do tempo
2026Hoje · 2026🧪 1982Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado6
3Fase 34
2Fase 25
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Poliomielite

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

317 ensaios clínicos encontrados, 16 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.514 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.514

#1

Estimating population immunity against serotype-two poliomyelitis from the inactivated polio vaccine in routine immunization across 112 countries: A modelling study.

PLoS medicine2026 Mar

To mitigate the risk of outbreaks of serotype 2 poliomyelitis after withdrawal of this serotype from oral poliovirus vaccine (OPV) in 2016, inactivated poliovirus vaccine (IPV) was introduced into the routine immunization (RI) programmes of all countries using OPV. Since 2022, WHO has recommended a 2-dose schedule, with a first dose at 14 weeks of age followed by a second dose at least 4 months later (e.g., 14-39 week schedule), although an earlier schedule may be adopted, despite lower immunogenicity, if vaccine coverage is low at older ages. We combined published data on type-2 IPV seroconversion with age, national RI coverage estimates, dose introduction dates, and country-specific schedules using a cohort model of population immunity to estimate IPV-induced immunity from 2024-2031 for 112 countries using either one or two doses of IPV. We projected immunity for current, 6-14, and 14-39 week schedules to find the optimal schedule and estimate the impact of interventions such as schedule changes and catch-ups. Under current schedules, estimated median serotype 2 population immunity in 2025 among children under five years of age is at 61% (IQR: 52%, 72%), rising to 71% (IQR: 57%, 80%) in 2031. The later 14-39 week schedule was optimal in all countries, with potential for the median immunity to rise to 78% (IQR: 66%, 85%) by 2031 if adopted by all countries in 2026. Eight countries would still have <50% immunity, rising to 65%-72% if catch-up campaigns with 80% coverage were implemented in 2030. The work is limited by the fact that IPV provides only a partial picture of total immunity where there has been emergency type-2 OPV use. Furthermore, national estimates may mask subnational coverage differences and pockets of extremely low immunity. Under these estimates, IPV schedules and coverage are suboptimal in many countries. Those with a single dose should introduce a second on the 14-39 week schedule; those on early schedules would benefit from adopting the 14-39 week schedule. IPV catch-up campaigns are recommended where RI coverage is low.

#2

Leveraging community insights and navigating logistical challenges: a case study of the 2024 polio vaccination campaign in Gaza, State of Palestine.

BMJ global health2026 Mar 02

This case study describes how high vaccination coverage was achieved during the 2024 polio vaccination campaign in Gaza amid an ongoing humanitarian crisis marked by damaged critical infrastructure, an obstruction of the entry of health supplies, mass displacement and security concerns for health workers. Despite the immense challenges, 559 161 children were vaccinated in the first round (94% of the revised target of 591 714) and 556 774 in the second round, exceeding expectations. While this represents an impressive achievement, some areas remained inaccessible, which prevented an estimated 7000-10 000 children from being reached for vaccination.Strong coordination and collaboration stewarded by the Gaza Ministry of Health with support from national and international partners.Negotiated humanitarian pauses in the form of 'days of tranquillity' agreed to by parties to the conflict enabling safe access for vaccinators, outreach teams and families.Prevaccination campaign sociobehavioural research to identify barriers and map information flows.Community engagement led by locally recruited volunteers embedded within affected communities, many of whom had themselves experienced displacement, supporting trust and acceptance.Culturally responsive communication strategies using multiple channels and feedback mechanisms.Adaptive vaccine management strategies and the development of a mobile cold chain.The campaign's success was underpinned by a multifaceted approach that included:Strong coordination and collaboration stewarded by the Gaza Ministry of Health with support from national and international partners.Negotiated humanitarian pauses in the form of 'days of tranquillity' agreed to by parties to the conflict enabling safe access for vaccinators, outreach teams and families.Prevaccination campaign sociobehavioural research to identify barriers and map information flows.Community engagement led by locally recruited volunteers embedded within affected communities, many of whom had themselves experienced displacement, supporting trust and acceptance.Culturally responsive communication strategies using multiple channels and feedback mechanisms.Adaptive vaccine management strategies and the development of a mobile cold chain.This case demonstrates that even in complex humanitarian crises, effective, community-centred vaccination strategies are possible. It also highlights how access and availability, not parental reluctance (or vaccine hesitancy), were the primary constraints on coverage. Parents showed strong willingness to vaccinate when services were accessible. Sustained advocacy and diplomacy remain essential to secure access, deliver equitable immunisation and create an enabling environment for humanitarian public health responses in conflict settings. However, the gains achieved through this campaign cannot meaningfully be sustained without a lasting ceasefire, the restoration of essential services and ongoing humanitarian access, particularly for infants born after the vaccination campaign who remain at heightened risk.

#3

Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays.

PloS one2026

Poliovirus eradication efforts have relied on effective vaccination campaigns and stringent laboratory containment of poliovirus strains. Serological testing is the primary means to address population immunity, vaccine efficacy, and individual poliovirus exposures. However, strict containment requirements for Sabin type 2 and wild poliovirus types 2 & 3 limit access to serological testing. To address these limitations, we evaluated the performance of hyper-attenuated, temperature-sensitive S19 poliovirus strains (S19-PV), which retain the antigenic characteristics of Sabin and Salk strains but can be handled under biosafety level 2 (BSL-2) conditions. Using a modified microneutralization assay, we performed a comparative validation of S19-PVs to their Sabin and wild-type counterparts using WHO international standards, in-house control reagents, and human sera. Neutralizing antibody titers showed strong concordance between S19-PV and reference strains (R² = 0.93-0.99), with high intra- and inter-assay reproducibility (CVs < 10%). Our findings demonstrate that S19-PV strains are antigenically equivalent to Sabin and wild-type viruses and suitable for use in neutralization assays to determine levels of poliovirus neutralizing antibodies outside of strict containment laboratories. Adoption of these strains can significantly expand global capacity for poliovirus serological testing, supporting surveillance and immunization activities in the final stages of poliovirus eradication.

#4

Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions.

International journal of molecular sciences2026 Jan 27

Kaposi's Sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) are oncogenic gammaherpesviruses with high prevalence in sub-Saharan Africa. Both viruses are typically acquired during childhood, establishing lifelong latency. While viral reactivation into the lytic cycle has been mainly studied in adult HIV-infected populations-and more recently in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection-the dynamics of KSHV and EBV infection in children remain poorly understood. Here, we characterize pediatric patients (n = 175; median age 4.6 years; IQR 2.0-8.3) presenting with inflammatory conditions during the COVID-19 pandemic in South Africa (from July 2020 to February 2024). Including a healthy, non-inflammatory control group, we found widespread exposure to SARS-CoV-2 (70.9% seropositivity), with 72.6% of the children being seropositive for EBV and 19.4% for KSHV. There were no significant differences in seroprevalence between children with inflammatory conditions and healthy controls for any of these viruses, although SARS-CoV-2 antibody titers were significantly higher in the inflammatory group, while EBV immune responses were lower in children presenting with inflammation. Among the KSHV-seropositive children, no active viremia was detected (as determined by the absence of viral DNA in the peripheral blood). In contrast, 34.4% of EBV-seropositive children had detectable EBV viral load, with a modestly higher proportion in the inflammatory group. However, EBV viral load levels were comparable between children diagnosed with Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease (KD), and other inflammatory conditions. Logistic regression analyses revealed that increasing age was significantly associated with higher risk of SARS-CoV-2 and EBV seropositivity, but not KSHV. Notably, the risk of EBV DNA detection in the peripheral blood decreased with age. In summary, this study suggests effective immunological control of gammaherpesvirus infections in HIV-negative paediatric patients, even in the presence of inflammatory conditions that might otherwise trigger viral reactivation.

#5

Chronobiology of neurotropic viruses: rhythmic viral entry and arrhythmic host clocks.

Cell discovery2026 Feb 10

Neurotropic viruses invade neural tissues, resulting in severe diseases such as poliomyelitis, rabies, herpesviral encephalitis, and viral meningitis. Given this neurotropism, we investigated whether the infection of the host by these viruses is under circadian control. In this study, we found that the expression of most neurotropic virus receptors exhibits rhythmicity across cells, cerebral organoids, and animal models, with host cell susceptibility modulated by the circadian clock. We identified E2F8 as a clock-controlled gene that mediates the indirect regulation of the circadian clock on neurotropic viruses. Notably, E2F8 regulated the expression of core clock components by binding directly to the promoters of REV-ERBα and PER2, suggesting its role as a potential modulator of circadian rhythms. Additionally, we revealed a seldom-recognized viral strategy to accelerate viral replication in the host: rabies virus disrupts the host circadian clock system primarily through its glycoprotein hijacking the E3 ubiquitin ligase HUWE1 to inhibit proteasomal degradation of REV-ERBα. These findings increase our understanding of the interactions between circadian systems and neurotropic viral dynamics and highlight the potential of chronotherapy for improved antiviral treatments.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC12.232 artigos no totalmostrando 198

2026

Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics.

Journal of virology
2026

Development and evaluation of an assay for the detection of tick-borne encephalitis virus RNA via real-time PCR with reverse transcription.

Parasites &amp; vectors
2026

A review of the current anti-Cryptococcus antifungals and emerging treatment strategies.

New microbes and new infections
2026

Estimating population immunity against serotype-two poliomyelitis from the inactivated polio vaccine in routine immunization across 112 countries: A modelling study.

PLoS medicine
2026

Application of a humeral intramedullary nail for subtrochanteric fracture in a patient with poliomyelitis sequelae: a case report.

Frontiers in surgery
2026

Total Knee Arthroplasty in Post-Polio Residual Paralysis: A Systematic Review and Pooled Analysis of Its Outcomes and Complications.

The Journal of arthroplasty
2026

Modified Lambrinudi Combined With X-Shaped Plate Internal Fixation for Triple Arthrodesis.

Foot &amp; ankle international
2026

Poliomyelitis, the years before vaccination. A reading through art.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Machine learning framework for early detection of polio outbreaks from acute flaccid paralysis surveillance data.

Virology
2026

Leveraging community insights and navigating logistical challenges: a case study of the 2024 polio vaccination campaign in Gaza, State of Palestine.

BMJ global health
2026

Genetic Diversity and Excretion Kinetics of Enteroviruses Excreted by Patients with Primary Immunodeficiency in Tunisia over a Five-Year Period (2020-2024).

Microorganisms
2026

Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays.

PloS one
2026

Case Report: Infant with vaccine-associated paralytic poliomyelitis unveils global disparities in care for inborn errors of immunity.

Frontiers in immunology
2026

Immunogenicity, Safety and Immune Persistence of Sabin Strain Inactivated Poliovirus Vaccine: A Phase III Clinical Trial.

Scandinavian journal of immunology
2025

Quality of life and associated factors in tunisian postpoliomyelitis syndrome patients.

La Tunisie medicale
2026

Determining the presence of restless legs syndrome in patients with poliomyelitis sequelae and its effect on pain, fatigue, sleep and quality of life.

Sleep &amp; breathing = Schlaf &amp; Atmung
2026

Digitising payments for campaign health workers in Africa: the promise and the path to sustainable scale.

BMJ global health
2026

[Late-onset sequel states of poliomyelitis (postpolyomelitic syndrome)].

Revista espanola de salud publica
2026

Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions.

International journal of molecular sciences
2026

[Temporal and spatial heterogeneities of childhood vaccination coverage in Brazilian state capitals: a methodological proposal using an applied and expected dose ratio].

Cadernos de saude publica
2026

Safety evaluation of inactivated poliomyelitis vaccine.

Human vaccines &amp; immunotherapeutics
2026

Chronobiology of neurotropic viruses: rhythmic viral entry and arrhythmic host clocks.

Cell discovery
2026

Prediction of recent HIV-1 infections using Shannon entropy analysis of HIV-1 group-specific antigen protein sequence.

Virology journal
2026

Preliminary safety evaluation of a diphtheria, tetanus, acellular component pertussis, Sabin inactivated poliovirus and Haemophilus influenzae type b combination vaccine (DTacP-sIPV/Hib).

Vaccine
2026

Specific determination of influenza virus A by SERS-active spike-like track-etched membranes.

Analytica chimica acta
2025

Preclinical Study on Sabin Strain-Based DTaP-sIPV/Hib Pentavalent Vaccine: Evaluation of Repeated-Dose Toxicity and Immunogenicity.

Vaccines
2025

Novel Multistage Subunit Mycobacterium tuberculosis Nanoparticle Vaccine Confers Protection Against Experimental Infection in Prophylactic and Therapeutic Regimens.

Vaccines
2025

Molecular Characterization of Avulaviruses Isolated from Mallard Ducks in Moscow in 2008-2024.

Veterinary sciences
2026

The role of the media in the coverage of childhood vaccination in children under two years of age in Peru, ENDES 2021-2024.

PLOS global public health
2026

Vaccine delay in routine childhood vaccines in the post-COVID-19 era in Jiangning, Nanjing, China.

Preventive medicine reports
2026

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda.

Nature microbiology
2026

Effectiveness of poliovirus environmental surveillance in Ghana: an indicator-based performance evaluation across seven regions, 2018-2022.

BMJ open
2026

Botulism Sequelae: A Systematic Review.

Open forum infectious diseases
2025

Post-pandemic assessment of parental perceptions toward COVID-19 vaccination and general immunization-an insight from polio endemic country.

Frontiers in public health
2026

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.

NAR molecular medicine
2026

Mind the gap: A qualitative assessment of limitations in school-age immunisation programme delivery for Orthodox Jewish children in northeast London.

Vaccine
2025

Tibialization of Fibula in an Implant Failure Non-Union Poliotic Limb: A Case Report.

Journal of orthopaedic case reports
2026

Digital twin frameworks for polio and post-polio neurodegeneration: Toward predictive, personalised lifelong neuro-rehabilitation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Tick-borne encephalitis virus variants drive distinct TCR repertoire alterations.

Frontiers in immunology
2025

Double Trouble: Guillain-Barré Syndrome (GBS) Presenting as Overlapping Miller Fisher Syndrome (MFS) and Pharyngeal-Cervical-Brachial (PCB) Variant.

Cureus
2026

My Odyssey in Pediatrics & Neonatology : Based on 18th Dr. K. C. Chaudhuri and Dr. Amala Chaudhuri Oration, on 5th October 2025.

Indian journal of pediatrics
2026

Bjørn Ibsen: intensive care and the conundrum of prolonging death.

British journal of anaesthesia
2025

Surveillance of West Nile Virus in Tunisia: Evidence from Human and Entomological Investigation.

Viruses
2025

Implementation of Poliovirus Containment in Poliovirus Designated Facilities-United States, 2017-2024.

Pathogens (Basel, Switzerland)
2025

Mono-WNV and combined WNV/TBEV inactivated vaccine efficacy against a wide range of WNV and TBEV strains.

Frontiers in immunology
2025

Reconstruction With Peroneus Longus Allograft for Chronic Subtotal Patellar Tendon Lesion: Surgical Technique and Clinical Implications.

Cureus
2025

A century of weekly notifiable disease incidence data by province in Canada.

PLOS global public health
2025

Australian National Enterovirus Reference Laboratory annual report, 2024.

Communicable diseases intelligence (2018)
2026

MRI of Neurogenic Human Motor Units Following Poliomyelitis.

Muscle &amp; nerve
2026

Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.

Vaccine
2026

Insights on vaccine-derived poliovirus type 2 outbreaks and novel oral polio vaccine candidates.

Diagnostic microbiology and infectious disease
2026

The global threat of vaccine-preventable neurological diseases.

Nature reviews. Neurology
2025

A critical overview of the recent resurgence of polio in Pakistan as a public health concern for millions of children.

Annals of medicine and surgery (2012)
2025

Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: A Case Series and Clinical Reflections.

Cureus
2025

Factors associated with the circulation of vaccine-derived polioviruses in children under five in Kilwa, Haut-Katanga province, Democratic Republic of Congo, 2022-2023.

BMC infectious diseases
2025

Towards understanding a potential Cryptococcus neoformans environmental-host transmission route in agricultural settings.

One health (Amsterdam, Netherlands)
2025

[Duchenne de Boulogne: Pioneer of Neurology].

Brain and nerve = Shinkei kenkyu no shinpo
2025

In vivo and in vitro Models of Hepatitis B Virus Infection.

Biochemistry. Biokhimiia
2025

[Short-to-medium-term clinical efficacy of total hip arthroplasty with Pinnacle ES constrained liner in the treatment of femoral neck fractures associated with lower limb neuromuscular disorders].

Zhongguo gu shang = China journal of orthopaedics and traumatology
2025

The p48 isoform of the PA2G4/EBP1/ITAF45 oncoprotein is required for the encephalomyocarditis virus IRES-driven translation initiation.

Nucleic acids research
2026

Chlamydia trachomatis-specific T Cell Immunity Reflects Widespread Exposure in South African Adolescents and Young Women.

The Journal of infectious diseases
2024

[Current Status of Surveillance and Management for Maintaining Polio Eradication in the Republic of Korea].

Jugan geon-gang gwa jilbyeong
2025

Characterization of a Sabin-like type 2/3 recombinant poliovirus with a triple nucleotide deletion in the VP1 region isolated from sewage.

Virology journal
2025

Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spread.

Nature microbiology
2026

Molecular evolution and circulation dynamic of human non-polio enteroviruses across Africa.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Multiple African-origin circulating poliovirus-2 emergences identified in Israel: A reminder of an ongoing global challenge.

The Science of the total environment
2025

Atomic Force Microscopy of Poliovirus Particles After Inactivation by Chemical Methods and Accelerated Electrons.

Viruses
2025

Longitudinal Cohort Event Monitoring of MMR and DT-IPV Vaccination at 9 Years of Age in The Netherlands.

Pharmaceuticals (Basel, Switzerland)
2025

Genetic Diversity of Selected High-Risk HPV Types Prevalent in Africa and Not Covered by Current Vaccines: A Pooled Sequence Data Analysis.

International journal of molecular sciences
2025

HSBDF-Derived Bioactive Components Broadly Inhibit Enteroviruses by Targeting 3C Protease and Attenuating Inflammatory Responses.

Biology
2025

Acute Flaccid Paralysis in a Vaccinated Child With Primary Immunodeficiency: Difficulties With Diagnostics of Vaccine-Associated Paralytic Poliomyelitis.

Journal of medical virology
2025

The Production of Antibodies (1941) by F. M. Burnet or by Burnet, Freeman, Jackson and Lush: Collaboration in research.

Journal of medical biography
2025

Tracking poliovirus through wastewater: environmental surveillance insights from Haïti (2020-2023).

Applied and environmental microbiology
2025

Media reporting trends on disease outbreaks of COVID-19, polio, and cholera in Nigeria: a scoping review.

BMC public health
2025

A review on health system-based surveillance for acute flaccid paralysis: technological advancements, challenges, and outlooks.

Journal of health, population, and nutrition
2025

Aging with disability in polio survivors: a narrative review.

Ewha medical journal
2025

The global poliovirus eradication initiatives in Kano state, Nigeria: a case report on the African regional commission pre-certification visit and lessons learnt.

Frontiers in public health
2025

New approaches to measles eradication, with special reference to Africa.

The Pan African medical journal
2025

Implant-based oral rehabilitation in patients with special needs: a case report.

AME case reports
2025

Insufficient immune protection in preterm infants due to delayed or incomplete hexavalent vaccination.

Frontiers in immunology
2025

The low genetic diversity of the Jingmen tick virus in Guinea sheds light on the recent introduction of the virus to West Africa.

Parasites &amp; vectors
2025

Intra-host diversity of SARS-CoV-2 in children with long-term and short-term excretion in nasopharyngeal samples.

BMC infectious diseases
2025

Effectiveness of an Education Toolkit Delivered by Soap Operas Among Communities Living in Extreme Poverty in Improving Vaccination Confidence in the Philippines: Protocol for a Cluster Randomized Controlled Trial.

JMIR research protocols
2025

Immunogenicity and safety of polio vaccines in infants: a systematic review of randomized clinical trials.

Virology journal
2025

ARFGAP1 serves as a critical host factor during E30 infection: QS11 inhibits viral pathogenesis in hFcRn-IFNAR-/- mice.

Virology journal
2025

Continuous Circulation of Hepatitis E and A Viruses During COVID-19 Pandemic Lockdowns in Munich, Germany-Experience from Three Years of Wastewater Surveillance.

Microorganisms
2025

Assessing the Anti-Cryptococcus Antifungal Potential of Artemisinin.

International journal of molecular sciences
2025

Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges.

Vaccines
2025

Generation of Polyclonal Antibodies Against Sabin Poliovirus D- and H-Antigens and Their Application in ELISA.

Vaccines
2025

Preclinical Immunogenicity Evaluation of a DTacP-sIPV/Hib Combination Vaccine in Rodent Models Under Varying Formulations and Immunization Schedules.

Vaccines
2025

[Effect of inactivated whole-virion concentrated purified vaccine for the prevention of COVID-19 on clinical and biochemical blood parameters of immature rats].

Voprosy virusologii
2025

[Detection of the Liman tick virus (unclassified Chuviridae) in tick cell line HAE/CTVM8].

Voprosy virusologii
2025

Reduction in energy cost of walking is associated with improved ankle plantarflexion moment during mid-stance following ankle-foot orthosis treatment in polio survivors with calf muscle weakness.

Disability and rehabilitation
2025

Antibody response to tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b vaccines in allogeneic hematopoietic stem cell transplant adult recipients: A multicenter trial.

PloS one
2025

Optimizing preparedness and response for circulating vaccine derived poliovirus (cVDPV) outbreaks in the Eastern Mediterranean Region with a particular focus on cVDPV2.

Frontiers in public health
2025

The Diagnostic Difficulty of Acute, Disabling Neurology: Varicella-Zoster Virus Polyradiculopathy Presenting as Acute Flaccid Paraparesis in an Elderly Male Patient With a History of Poliomyelitis.

Cureus
2026

Genotype-dependent cell tropism of EV-A71 at the human blood cerebrospinal fluid and blood brain barrier.

Microbial pathogenesis
2025

[Current situation of people with polio and post-polio syndrome in Spain].

Revista espanola de salud publica
2025

Vaccine hesitancy and bone health: Musculoskeletal sequelae of vaccine-preventable diseases.

Osteoporosis and sarcopenia
2025

Evaluation of the acute flaccid paralysis surveillance system performance in the Upper West Region of Ghana from 2021 to 2023: a retrospective descriptive study.

BMJ open
2025

Self-reported poliomyelitis vaccination and documentation in adults indicates high uptake: a digital German epidemic panel, December 2024.

BMC public health
2025

NanoDeNovo: De Novo Design of Anti-Poliovirus I Sabin Strain Nanobodies by Semi-Automated Computational Pipeline.

International journal of molecular sciences
2025

Estimating proportions of missed children and reasons for non-vaccination following implementation of "reaching the unreached" multiantigen immunization campaign-south Khyber Pakhtunkhwa, Pakistan, July-August 2023.

Frontiers in public health
2025

Recent emergence of vaccine-derived poliovirus type 2 in Senegal and virus spread to neighboring countries.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Structural Barriers and the Future of AI in Global Health: Lessons From Eradicable Diseases.

Cureus
2026

Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines.

Clinical immunology (Orlando, Fla.)
2025

Primary Total Knee Arthroplasty in Patients Who Have Neuromuscular Disorders and Genu Recurvatum Using a Rotating-Hinge Implant: A Case Series With a Mean 4-Year Follow-Up.

The Journal of arthroplasty
2025

Distribution of Mukawa virus (Phlebovirus mukawaense) in Russia.

Virology journal
2025

Current status of BCG and OPV vaccination in children with primary immunodeficiency in Chongqing, China.

Medicine
2025

A novel approach to poliovirus vaccine neurovirulence testing: development of an enhanced 4-level scoring system.

Immunobiology
2025

The decrease in childhood vaccination coverage and its sociodemographic determinants, the Netherlands, birth cohorts 2008 to 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Staying polio free: A capture-recapture analysis of acute flaccid paralysis surveillance in the Australian Capital Territory.

Australian and New Zealand journal of public health
2025

Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates.

Frontiers in immunology
2025

Post-Polio Syndrome: Impact of Humoral Immune Deficiencies, Poliovirus Neutralizing Antibodies, Vitamin D Deficiency.

Vaccines
2025

The Omicron Wave in Tunisia: Dynamic, Diversity, and Phylogenetic Analyses.

Microorganisms
2025

Orthopaedic portrayals in The Seven Works of Mercy painted by a Dutch master in the year 1504.

International orthopaedics
2025

Effect of BCG Danish and oral polio vaccine on neonatal mortality in newborn babies weighing less than 2000 g in India: multicentre open label randomised controlled trial (BLOW2).

BMJ (Clinical research ed.)
2025

The public health and economic impact of the Greek pediatric national immunization program.

Expert review of vaccines
2025

Poliomyelitis: The paradigm of an eliminated disease: Sequelae and challenges to eradication.

Revista espanola de anestesiologia y reanimacion
2025

[Analysis of the immunization status and related factors for children aged 0-7 years old with special health status in Tianhe District, Guangzhou City from 2023 to 2024].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2025

Assessment of environmental surveillance for the detection of poliovirus implementation in the metropolitan districts of South Africa, 2020-2023.

The Pan African medical journal
2025

The effect of supporting districts to operationalise digital payments for vaccination campaign workers: a cluster randomised controlled trial during the 2022 polio vaccination campaign in Uganda.

BMJ global health
2025

Characterisation of a secreted MFSD6-Fc microbody as a decoy receptor for respiratory enterovirus D68.

EBioMedicine
2025

Potential Causal Relationships Between Circulating Micronutrient Levels and Multiple Neuroimmune Diseases: A Genetic Association Analysis.

Brain and behavior
2026

Poliovirus surveillance in Mayotte, Indian Ocean, reveals encephalomyocarditis virus type 1 and a wide diversity of non-polio enteroviruses.

Transactions of the Royal Society of Tropical Medicine and Hygiene
2025

Low-grade persistent poliovirus infection in long-term polio survivors diagnosed with post-polio syndrome: diagnostic and clinical implications.

Journal of neurology
2025

Poliomyelitis dynamics with fractional order derivatives and deep neural networks.

Scientific reports
2025

Application of a comprehensive approach to pathogen screening in a stowaway rat on an airplane.

Scientific reports
2025

Early detection of a circulating pre-vaccine-derived poliovirus type 1 (pre-VDPV1) variant linked to an acute flaccid polio case prior to VDPV1 emergence, Israel, 2024 to 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Exploring the Contextual Factors That Influence Polio Supplementary Immunisation Activities in the WHO African Region: A Rapid Review.

Vaccines
2025

Degradation of Poliovirus Sabin 2 Genome After Electron Beam Irradiation.

Vaccines
2025

Unveiling a Shift in the Rotavirus Strains in Benin: Emergence of Reassortment Intergenogroup and Equine-like G3P[8] Strains in the Post-Vaccination Era.

Viruses
2025

Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic Mice.

Viruses
2026

Political Polarization During Disease Outbreaks: A Meta-Analysis of Archival Survey Data From Polio to COVID-19.

American journal of public health
2025

Evidence of Subclinical Visual Pathway Dysfunction in Polio Survivors: A Visual Evoked Potential Study.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre
2025

Plummer-Vinson syndrome in a postpolio patient: a rare intersection of neuromuscular and nutritional sequelae.

BMJ case reports
2025

[Poliomyelitis vaccination: politics, problems and people. An unfinished story].

Revista espanola de salud publica
2025

Breaking barriers: a qualitative study on polio vaccine hesitancy in Herat Province, Afghanistan.

BMC public health
2025

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial.

The Lancet. Infectious diseases
2025

Lessons learned from upstream wastewater sampling in response to poliovirus in New York State.

The Science of the total environment
2025

Characteristics of four natural poliovirus type 1 variants with six-nucleotide deletion (2,783-2,788 nt) in the VP1 region.

Microbiology spectrum
2025

Collateral damage from violent incidents: human costs of polio immunization.

Bulletin of the World Health Organization
2025

Variation in HIV-1 Tat and Vpr protein amino acid sequences and its association with vascular health measures in a South African cohort: an exploratory study.

Virology journal
2025

The summer colonies: 'custodians' of the health of the young. Prophylaxis of infectious diseases and educational purposes in the reports of the school medical inspector Benedetto Barni (1893-1970) in the 1950s.

Journal of preventive medicine and hygiene
2025

Dual Mobility Acetabular Cup Utilization in Total Hip Arthroplasty: Mitigating Instability Risks.

Medical journal of the Islamic Republic of Iran
2025

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment.

Frontiers in public health
2025

Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus.

Vaccines
2025

Assessment of Oral Poliovirus Vaccine Viability and Titer at Delivery Points in Kinshasa, the Democratic Republic of the Congo: Implications for Cold Chain Management.

Vaccines
2025

Immune and Safety Analysis of ultraIPVTM, a Novel UVC-Inactivated Polio Vaccine.

Viruses
2026

Clinical and Environmental Surveillance of Poliovirus Type 2 Outbreak Using a Novel Specific Real-time Quantitative Polymerase Chain Reaction Assay, Israel, 2022-2023.

The Journal of infectious diseases
2025

Acute Transverse Myelitis in a Child Following Oral Live Polio Vaccine Administration.

International medical case reports journal
2025

Updates on the polio surveillance action plan's key performance indicators: East and Southern African countries (January 2022 to December 2023).

The Pan African medical journal
2025

Evaluation of acute flaccid paralysis surveillance system in Kebbi State, Nigeria between 2013-2018.

The Pan African medical journal
2025

Global Evolution and Transmission Dynamics of Enterovirus D68.

Journal of medical virology
2025

Polio vaccination campaigns in conflicts: succeeding while other humanitarian efforts fail?

Frontiers in public health
2025

A qualitative study on gender relations and digital payments: healthcare workers' experiences during polio vaccination campaigns in Uganda and Malawi.

BMJ global health
2025

Assessing early detection ability through spatial arrangements in environmental surveillance for poliovirus: A simulation-based study.

PloS one
2025

Surgical treatment of femoral medial condyle impaction fracture complicated with Hoffa fragment by contralateral medial distal tibia plate: a case report.

BMC musculoskeletal disorders
2025

Immunogenicity and safety of sequential Sabin strain inactivated poliovirus vaccine from different manufacturers in infants: Randomized, blinded, controlled trial.

Vaccine
2025

IGF-1 regulates LARP6-mediated collagen metabolism in vaginal fibroblasts of POP patients via the PI3K/AKT pathway.

Scientific reports
2025

Pathological characteristics of a murine oral coxsackievirus A10 infection model.

Journal of virology
2025

Genetic characterization of type 3 vaccine-derived poliovirus from a patient with hand, foot, and mouth disease in China.

Virology journal
2025

Supplementary Surveillance of Poliovirus Circulation in the Russian Federation: Results of a Study on Migrant Children of "Risk Group".

Viruses
2025

Porcine Teschovirus 2 3Cpro Evades Host Antiviral Innate Immunity by Inhibiting the IFN-β Signaling Pathway.

Microorganisms
2025

West Nile neuroinvasive disease with poliomyelitis syndrome: A grave phenomenon.

SAGE open medical case reports
2025

Reconstruction of a Chronic Quadriceps Tendon Rupture in an Elderly Polio Patient.

Biomedicines
2025

Effects of workforce volatility, determinants of infant deaths and resilience in SUS Primary Care.

Ciencia &amp; saude coletiva
2025

Bone biomarkers in post-polio clinic patients.

Frontiers in endocrinology
2026

Synthesis and antifungal properties of the new semiselenoglycolurils.

Molecular diversity
2025

Open Lip Schizencephaly Misdiagnosed as Paralytic Poliomyelitis in an 85-Year-Old: A Case Report.

Clinical case reports
2025

Preparedness and response to the international poliovirus and diphtheria reintroduction alert: public health interventions and strategy review in the Veneto Region, Italy.

Frontiers in public health
2025

Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
2025

[MEDICAL REHABILITATION DURING WAR: THE HISTORICAL PERSPECTIVE].

Harefuah
2025

Creating cohesive communities: using Conditional-Collective-Community-Based Incentives to change social norms on polio immunization in Pakistan.

Frontiers in public health
2025

Determinants of incomplete immunization and factors for missed opportunities in urban Dhaka: A cross-sectional study.

PloS one
2025

[Poliomyelitis in Spain: from the past to the present, a continuous challenge].

Revista espanola de salud publica
2025

Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.

The Lancet. Infectious diseases
2025

Emerging neuroinfectious diseases: public health implications.

Current opinion in neurology
2025

T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination.

Communications medicine
2025

Vaccination policies for dentists and other dental professionals in Europe: a systematic report.

Expert review of vaccines
2025

Evolution and transmission dynamics of wild poliovirus in Pakistan and Afghanistan (2012-2023).

Nature communications
2025

Estimating epidemic dynamics with genomic and time series data.

Journal of the Royal Society, Interface
2025

Immune cells promote paralytic disease in mice infected with enterovirus D68.

The Journal of clinical investigation
2025

varVAMP: degenerate primer design for tiled full genome sequencing and qPCR.

Nature communications
2025

The Tryptophan-Kynurenine pathway in people living with HIV: a systematic review.

Infection
2025

Acute flaccid myelitis in Europe between 2016 and 2023: indicating the need for better registration.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Understanding barriers to stool adequacy: results from a programmatic assessment of Pakistan's acute flaccid paralysis active surveillance system in 12 priority districts.

Frontiers in public health
2025

Safety of nOPV2 administered during a supplementary immunisation activity in Uganda, 2022: data triangulation from a prospective cohort event monitoring programme and vaccine safety surveillance reports.

The Lancet. Global health
2025

Investigation and response to a type 3 vaccine-derived poliovirus detected in an infant with hand, foot, and mouth disease - Guangdong, China, 2023.

Journal of health, population, and nutrition
2025

Achievements and Obstacles in the Late Phase of the Global Polio Eradication Initiative.

Deutsches Arzteblatt international
2025

The association of oral polio vaccine doses and severity of paralysis: an analysis of wild poliovirus type 1 cases in Pakistan.

Infectious diseases (London, England)
2025

[The role of international research stays and the European context of polio control in Spain].

Revista espanola de salud publica
2025

Interrelationship between the Non-Vesicular Transport of Sterols and Their Distribution between the Rafts and the Non-Raft Phase of the Plasma Membrane.

Biochemistry. Biokhimiia
2025

[Technical cooperation strategies to revitalize immunization programs in priority countries in the AmericasEstratégias de cooperação técnica para revitalização do programa de imunização em países prioritários da Região das Américas].

Revista panamericana de salud publica = Pan American journal of public health
2025

Anterolateral thigh flap harvested from paralyzed limbs in post-polio syndrome for tongue reconstruction-a case report and a review of the literature.

Chinese clinical oncology
2025

Genotype I Newcastle Disease Virus, Isolated from Wild Duck, Can Protect Chickens Against Newcastle Disease Caused by Genotype VII.

Pathogens (Basel, Switzerland)
2025

Polio vaccination and marginal effects among children aged 12-23 months in Lesotho using 2024 LDHS data: A multilevel analysis approach.

PloS one
2025

Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials.

The Lancet. Microbe
Ver todos os 12.232 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Poliomielite.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Poliomielite

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Estimating population immunity against serotype-two poliomyelitis from the inactivated polio vaccine in routine immunization across 112 countries: A modelling study.
    PLoS medicine· 2026· PMID 41855197mais citado
  2. Leveraging community insights and navigating logistical challenges: a case study of the 2024 polio vaccination campaign in Gaza, State of Palestine.
    BMJ global health· 2026· PMID 41771665mais citado
  3. Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays.
    PloS one· 2026· PMID 41730007mais citado
  4. Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions.
    International journal of molecular sciences· 2026· PMID 41683701mais citado
  5. Chronobiology of neurotropic viruses: rhythmic viral entry and arrhythmic host clocks.
    Cell discovery· 2026· PMID 41663379mais citado
  6. Evaluation of Coverage Rates of 3 Pediatric Vaccines (Measles-Mumps-Rubella, Hexavalent, and Varicella) in a Southern Italian Province (2016-2022): Effect of the Pandemic and Interregional Comparisons.
    Med Sci Monit· 2026· PMID 41961762recente
  7. Steindler flexorplasty in the management of elbow flexion deficits due to musculocutaneous nerve palsy: medium and long-term outcomes in two cases.
    JSES Rev Rep Tech· 2026· PMID 41953367recente
  8. Characteristics of Polish travellers admitted at the University Centre of Maritime and Tropical Medicine in Poland, 2024-2025.
    Int Marit Health· 2026· PMID 41914195recente
  9. Association of Plasma and Cerebrospinal Fluid Glucose Level with Clinical Severity in Patients with Guillain-Barre Syndrome.
    Mymensingh Med J· 2026· PMID 41914086recente
  10. Safety of Sabin-Strain Inactivated Poliovirus Vaccine Administered Alone or Concomitantly with Other Vaccines: A Population-Based Post-Marketing Surveillance Study.
    Vaccines (Basel)· 2026· PMID 41893778recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2912(Orphanet)
  2. MONDO:0017373(MONDO)
  3. GARD:7413(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)
  6. Q12195(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Poliomielite
Compêndio · Raras BR

Poliomielite

ORPHA:2912 · MONDO:0017373
Prevalência
<1 / 1 000 000
Herança
Not applicable
CID-10
A80.4 · Poliomielite aguda não-paralítica
CID-11
Ensaios
16 ativos
Início
Childhood
Prevalência
0.0 (Europe)
MedGen
UMLS
C0032371
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades